Medication-Overuse Headache (Investigational Adjunct)

Patienten-Zusammenfassung

Ist dies FDA-zugelassen fuer diese Anwendung?

Not FDA-cleared for medication overuse headache. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use for medication overuse headache is investigational.

Welche Evidenz existiert?

Tier C (investigational). Only anecdotal reports; there are no randomized controlled trials. Evidence-based management of medication overuse headache: discontinuation of overused acute medications (gradual or abrupt depending on agent), initiation of preventive therapy (topiramate, propranolol, amitriptyline, CGRP monoclonal antibodies, onabotulinumtoxinA for chronic migraine), and patient education. Most patients improve significantly within 8 weeks of withdrawal with appropriate support.

Hauptrisiken

• Bleeding from bite sites for 6 to 24 hours after detachment
• Trigger of withdrawal headache or rebound migraine
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Worsening headache after the procedure
• Substitution for the essential step of discontinuing overused medication
• Delay of preventive therapy (topiramate, propranolol, CGRP monoclonal antibodies, onabotulinumtoxinA)
• Risk of missed secondary headache cause (intracranial hypertension, cerebral venous thrombosis)

Wer dies nicht in Betracht ziehen sollte

• Patients who have not yet discontinued their overused acute medication
• Patients without a neurology evaluation for secondary causes
• Patients on barbiturate or opioid overuse (requires inpatient withdrawal in some cases)
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Pregnant patients
• Patients who have not been offered preventive therapy

Was Sie Ihren Kliniker fragen sollten

• Have I been evaluated by a neurologist for medication overuse headache?
• Have I begun the process of discontinuing overused acute medications?
• Have I been offered preventive therapy (topiramate, propranolol, amitriptyline, CGRP mAb)?
• Am I a candidate for onabotulinumtoxinA (chronic migraine indication)?
• Has a secondary headache cause been ruled out (MRI, lumbar puncture if indicated)?
• What evidence specifically supports leech therapy for medication overuse headache?
• What is the cost and is it covered by insurance? (typically not covered)

Wann dringende medizinische Versorgung suchen

• Sudden severe headache (worst of life — rule out subarachnoid hemorrhage)
• New weakness, numbness, slurred speech, or vision loss (possible stroke)
• Headache with fever and neck stiffness (possible meningitis)
• Headache with vision changes or papilledema (possible intracranial hypertension)
• Spreading redness, warmth, pus, or red streaks (cellulitis)
• Fever above 38.0 C / 100.4 F or chills
• Bleeding from a bite site lasting more than 24 hours
• Hives, facial or tongue swelling, throat tightness, or breathing difficulty